Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Amyloid PET Imaging: Standard Procedures and SemiquantificationFrancesca D'Amico, Luca Sofia, Matteo Bauckneht, et al.
Diagnostics (Basel, Switzerland)|September 9, 2023
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CTAnnalice Gandini, Matteo Bauckneht, Luca Sofia, et al.
Neurology|October 10, 2025
Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy SpectrumBeatrice Orso, Pietro Mattioli, Francesco Famà, et al.
Brain Sciences|January 28, 2026
The Inflammatory Side of Iatrogenic Cerebral Amyloid Angiopathy: Rethinking Therapeutic OpportunitiesMattia Losa, Andrea Donniaquio, Ilaria Gandoglia, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 23, 2024
Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patientsStefano Raffa, Luca Sofia, Nicola Girtler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 6, 2026
[<sup>18</sup>F]Fluorodeoxyglucose positron emission tomography ([<sup>18</sup>F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy ContinuumBeatrice Orso, Ignacio Roura, Pietro Mattioli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2025
[<sup>18</sup>F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patientsMatteo Bauckneht, Giovanni Pasini, Tania Di Raimondo, et al.
Current Problems in Cancer|September 8, 2023
The prognostic value of FIGO staging defined by combining MRI and [<sup>18</sup>F]FDG PET/CT in patients with locally advanced cervical cancerStefano Raffa, Francesco Lanfranchi, Camilla Satragno, et al.
European Urology Oncology|April 30, 2025
Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography/Computed TomographyFrancesca Ambrosini, Nataniele Piol, Matteo Bauckneht, et al.
Annals of Nuclear Medicine|October 10, 2025
Baseline PSMA tumor volume as a prognostic marker in radical radiotherapy for prostate cancer: a propensity score-weighted retrospective analysisFrancesco Lanfranchi, Liliana Belgioia, Daniele Vita, et al.
Pageof 2